NEUP

2.3501.29%
MB

Murray B. Stein

Member of Clinical Advisory Board

Dr. Murray B. Stein, M.D., M.P.H., FRCPC, is Member of Clinical Advisory Board at Sensorium Therapeutics, Inc. from May 2026. He is Member of Clinical Advisory Board of Newleos Therapeutics, Inc. from April 2025 and Incannex Healthcare Inc. since January 2026. Dr. Stein served as Scientific and Clinical Advisors of Seaport Therapeutics Inc. Dr. Stein serves as Member of Scientific Advisory Board at Oxeia Biopharmaceuticals, Inc. Dr. Stein serves as Member of Clinical Advisory Board at Neuphoria Therapeutics Inc. (formerly known as Bionomics Limited). Dr. Stein is Distinguished Professor of Psychiatry and Family Medicine & Public Health and Vice Chair for Clinical Research in Psychiatry at the University of California San Diego (UCSD). He is also a Staff Psychiatrist at the VA San Diego Healthcare System. Dr. Stein’s research interests include the epidemiology, neurobiology and treatment of anxiety disorders especially social phobia, panic disorder and posttraumatic stress disorder. He is also very interested in the relationship of mild traumatic brain injury (concussion) to mental disorders. He has written or co written over 500 peer reviewed scientific articles on these topics, including in journals such as Journal of the American Medical Association, The Lancet, American Journal of Psychiatry and JAMA Psychiatry. He is co editor, with Martin Antony PhD, of the Oxford Handbook of Anxiety and Related Disorders (2009). His federally funded research has included studies of interventions for anxiety disorders in primary care, pharmacological approaches to treatment resistant anxiety and stress related disorders and functional neuroimaging research in anxiety and trauma related disorders. He is Principal Investigator and Director of the Department of Defense funded (2008 2016) INjury and TRaumatic STress (INTRuST) Consortium, which studies treatments for Posttraumatic Stress Disorder and Traumatic Brain Injury. He is also Co Principal Investigator (with Robert Ursano MD) of Army STARRS, an NIMH funded project (2009 2015) investigating risk factors for suicide, PTSD, TBI and other deployment related disorders. Dr. Stein is a member of the Scientific Advisory Board of the Anxiety and Depression Association of America (ADAA), a Fellow of the American College of Neuropsychopharmacology (ACNP), Co Editor in Chief for UpToDate in Psychiatry and Deputy Editor for the journal Biological Psychiatry. Dr. Stein chaired the American Psychiatric Association Workgroup to Revise the Panic Disorder Treatment Guidelines (2006 2008) and is past Scientific Chair of the NIMH Interventions in Mood and Anxiety (ITMA) Review Group (2006 2009). Dr. Stein was a member of the DSM 5 Anxiety, Obsessive Compulsive Spectrum, Posttraumatic and Dissociative Disorders Work Group (2009 2013). He is a member of the Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee (PDAC) (2011 2016) and a past member of the Institute of Medicine (IOM) Board on the Health of Select Populations (2012 2015). Dr. Stein is also a member of the Steering Committee for the Traumatic Brain Injury Endpoints Initiative, launched in 2014. Dr. Stein graduated from the University of Manitoba and completed his residency and post residency fellowship at the University of Toronto and at the National Institute of Mental Health in Bethesda, Maryland, USA. He subsequently completed a Master of Public Health degree at the Johns Hopkins University Bloomberg School of Public Health in Baltimore, Maryland.

Positions